Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders

被引：2
|
作者：
Vassallo, Matteo [1 ]
De Monte, Anne [2 ]
Durant, Jacques [3 ]
Dunais, Brigitte [4 ]
Cottalorda, Jacqueline [2 ]
机构：
[1] Cannes Gen Hosp, Dept Internal Med Infect Dis, Cannes, France
[2] Nice Univ Hosp, Virol Unit, Nice, France
[3] Nice Univ Hosp, Dept Infect Dis, Nice, France
[4] Nice Univ Hosp, Dept Publ Hlth, Nice, France
来源：
AIDS | 2016年 / 30卷 / 14期
关键词：
RESISTANCE SUBSTITUTIONS; VIRAL REPLICATION; CAPACITY;
D O I：
10.1097/QAD.0000000000001194
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2257 / 2258
页数：2
相关论文
共 50 条
  • [1] The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
    Mesplede, Thibault
    Leng, Jing
    Hanh Thi Pham
    Liang, Jiaming
    Quan, Yudong
    Han, Yingshan
    Wainberg, Mark A.
    MBIO, 2017, 8 (02):
  • [2] The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir
    Oliveira, Maureen
    Mesplede, Thibault
    Moisi, Daniela
    Ibanescu, Ruxandra-Ilinca
    Brenner, Bluma
    Wainberg, Mark A.
    AIDS, 2015, 29 (17) : 2255 - 2260
  • [3] Development of the R263K Mutation to Dolutegravir in an HIV-1 Subtype D Virus Harboring 3 Class-Drug Resistance
    Ahmed, N.
    Flavell, S.
    Ferns, B.
    Frampton, D.
    Edwards, S. G.
    Miller, R. F.
    Grant, P.
    Nastouli, E.
    Gupta, R. K.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (01):
  • [4] Cerebrospinal fluid and plasma biomarkers in patients with HIV-associated neurocognitive disorders
    Trunfio, Mattia
    Vai, Daniela
    Romito, Alessandra
    Atzori, Cristiana
    Imperiale, Daniele
    Audagnotto, Sabrina
    Montrucchio, Chiara
    Scabini, Silvia
    Cardellino, Chiara
    Pirriatore, Veronica
    Di Perri, Giovanni
    Bonora, Stefano
    Calcagno, Andrea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [5] Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders
    Teresa H. Evering
    Current HIV/AIDS Reports, 2018, 15 : 72 - 83
  • [6] Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders
    Evering, Teresa H.
    CURRENT HIV/AIDS REPORTS, 2018, 15 (01) : 72 - 83
  • [7] The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
    Wainberg, Mark
    Anstett, Kaitlin
    Mesplede, Thibault
    Quashie, Peter
    Han, Yingshan
    Oliveira, Maureen
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 21 - 21
  • [8] Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda
    Abassi, Mahsa
    Morawski, Bozena M.
    Nakigozi, Gertrude
    Nakasujja, Noeline
    Kong, Xiangrong
    Meya, David B.
    Robertson, Kevin
    Gray, Ronald
    Wawer, Maria J.
    Sacktor, Ned
    Boulware, David R.
    JOURNAL OF NEUROVIROLOGY, 2017, 23 (03) : 369 - 375
  • [9] Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda
    Mahsa Abassi
    Bozena M. Morawski
    Gertrude Nakigozi
    Noeline Nakasujja
    Xiangrong Kong
    David B. Meya
    Kevin Robertson
    Ronald Gray
    Maria J. Wawer
    Ned Sacktor
    David R. Boulware
    Journal of NeuroVirology, 2017, 23 : 369 - 375
  • [10] An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China
    Yulin Zhang
    Luxin Qiao
    Wei Ding
    Feili Wei
    Qingxia Zhao
    Xicheng Wang
    Ying Shi
    Ning Li
    Davey Smith
    Dexi Chen
    Journal of NeuroVirology, 2012, 18 : 120 - 126
12345